tiprankstipranks
Advertisement
Advertisement
Veru price target lowered to $24 from $25 at Oppenheimer
PremiumThe FlyVeru price target lowered to $24 from $25 at Oppenheimer
3M ago
Veru Inc. Earnings Call Highlights Clinical Momentum
Premium
Company Announcements
Veru Inc. Earnings Call Highlights Clinical Momentum
3M ago
Veru reports Q2 EPS (37c) vs. ($1.15) last year
Premium
The Fly
Veru reports Q2 EPS (37c) vs. ($1.15) last year
3M ago
Veru Targets GLP-1 Muscle Loss Risk With New Enobosarm Combo Study
PremiumCompany AnnouncementsVeru Targets GLP-1 Muscle Loss Risk With New Enobosarm Combo Study
5M ago
Veru enrolls first patient in Phase 2b PLATEAU trial of enobosarm
Premium
The Fly
Veru enrolls first patient in Phase 2b PLATEAU trial of enobosarm
5M ago
Veru Inc. Charts Risky but Clearer Post-GLP-1 Path
Premium
Company Announcements
Veru Inc. Charts Risky but Clearer Post-GLP-1 Path
6M ago
Options Volatility and Implied Earnings Moves Today, December 17, 2025
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, December 17, 2025
8M ago
Options Volatility and Implied Earnings Moves This Week, December 15 – December 19, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, December 15 – December 19, 2025
8M ago
Is VERU a Buy, Before Earnings?
Premium
Pre-Earnings
Is VERU a Buy, Before Earnings?
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100